Short Communication Open Access
Volume 1 | Issue 3 | DOI: https://doi.org/10.33696/cancerbiology.1.012
Prognostic Role of Human Epididymis Protein 4 (HE4) in Ovarian Cancer Treatment: Our Point of View
MESSINA Giuseppe1,*, PLOTTI Francesco1, TERRANOVA Corrado1, MONTERA Roberto1, DE CICCO NARDONE Carlo1, GUZZO Federica1, LUVERO Daniela1, GATTI Alessandra1, SCHIRO Teresa1, ROSSINI Gianmarco1, DE LUCA Cristiana1, FICAROLA Fernando1, MASULLI Clara1, VITIELLO Francesca1, FEOLE Laura1, PERRONE Chiara1, RAMPELLO Stefania1, ANGIOLI Roberto1
- 1Campus Bio-Medico University of Rome, Department of Gynecology and Obstetrics, Italy
Corresponding Author
MESSINA Giuseppe, g.messina@unicampus.it
Received Date: October 05, 2020
Accepted Date: November 02, 2020
Giuseppe M, Francesco P, Corrado T, Roberto M, Carlo DCN, Federica G, et al. Prognostic Role of Human Epididymis Protein 4 (HE4) in Ovarian Cancer Treatment: Our Point of View. Arch Cancer Biol Ther. 2020; 1(3): 55-58.
Copyright: © 2020 Giuseppe M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Botulinum Toxin: The Promising Future of Prostate Cancer Treatment
Peripheral nerves have been shown to modulate the growth and spread of tumours in the prostate, feeding both cancer cells and the stroma in the tumour environment. Several in vitro and in vivo studies have reported the effect of botulinum toxin (BT) on tumour tissue in the prostate. BT in humans has been observed to cause increased apoptosis of cancer cells, with morphological changes characterized by extensive degenerative and atrophic areas of cancer, reduced cytoplasm, and pyknotic nuclei, compared to the characteristics of cancer tissues injected with saline solution.
NOXA the BCL-2 Family Member behind the Scenes in Cancer Treatment
NOXA is a critical mediator of stress responses to anticancer drugs. This BH3-only protein sets the apoptotic threshold in cancer cells in response to chemotherapies by counteracting the prosurvival BCL-2 family protein MCL-1. A complex and dynamic network relying on both highly controlled gene transcription activity and protein degradation by proteasome, regulates cellular NOXA levels from low in steady state to rapidly enhanced upon stressful condition.
Relevance of Neuropilin 1 and Neuropilin 2 Targeting for Cancer Treatment
Neuropilins (NRPs) are a class of transmembrane glycoprotein co-receptors including Neuropilin 1 (NRP1) and Neuropilin 2 (NRP2). They are the co-receptors of different families of receptors, thus they are involved in many hallmarks of cancer.
Biomarkers of Pembrolizumab Efficacy in First-Line Advanced PD-L1 ≥ 50% Non-Small Cell Lung Cancer Treatment
Lung cancer is the leading cause of cancer death worldwide. In 2020, a total of 19 million cancer patients were diagnosed, of which 11.4% were lung cancer, causing 18% of all cancer deaths. In 2020 in Spain, 29,638 cases were estimated.
A Brief Update on STAT3 Signaling: Current Challenges and Future Directions in Cancer Treatment
Signal transducer and activator of transcription (STAT) 3 plays a key role not only in regulating a variety of biological properties, including survival, proliferation, and metastasis of cancer cells, but also in modifying the tumor microenvironment to promote angiogenesis and immunosuppression, rendering STAT3 a valuable target in cancer.